SPIA
RCEL icon

Steward Partners Investment Advisory’s Avita Medical RCEL Stock Holding History

Steward Partners Investment Advisory’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-52
Closed -$834 – 3696
2024
Q1 		$834 Hold
52
– – ﹤0.01% 3388
2023
Q4 		$713 Buy
+52
New +$596 ﹤0.01% 3331
2022
Q2 		– Sell
-195
Closed -$2K – 3346
2022
Q1 		$2K Sell
195
-50
-20% -$461 ﹤0.01% 3107
2021
Q4 		$3K Sell
245
-318
-56% -$4.85K ﹤0.01% 2960
2021
Q3 		$10K Sell
563
-97
-15% -$1.83K ﹤0.01% 2606
2021
Q2 		$14K Sell
660
-437
-40% -$8.61K ﹤0.01% 5616
2021
Q1 		$21.7K Sell
1,097
-1,150
-51% -$26.7K ﹤0.01% 2432
2020
Q4 		$42K Sell
2,247
-1,657
-42% -$36.3K ﹤0.01% 1745
2020
Q3 		$98K Buy
3,904
+645
+20% +$16.1K ﹤0.01% 1231
2020
Q2 		$100K Buy
3,259
+753
+30% +$23K ﹤0.01% 1155
2020
Q1 		$77K Buy
2,506
+1,167
+87% +$48.3K ﹤0.01% 1096
2019
Q4 		$60K Buy
+1,339
New +$55.6K ﹤0.01% 1325

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Steward Partners Investment Advisory's RCEL Position: Q2 2024 in Review

Steward Partners Investment Advisory sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 52 shares — an estimated $834 sold.

Steward Partners Investment Advisory first reported a position in RCEL in Q4 2019 and held it in 12 quarters. The position peaked at $100K in Q2 2020. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • Steward Partners Investment Advisory reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 52 Avita Medical shares in Q2 2024, an estimated $834.
  • Steward Partners Investment Advisory first reported a position in Avita Medical in Q4 2019 and held it in 12 quarters.
  • Steward Partners Investment Advisory's Avita Medical position peaked at $100K in Q2 2020.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2024, filed 8 Aug 2024.